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The importance of thiazide-induced hyponatremia (TIH) is reemerging because 
thiazide diuretic prescription seems to be increasing after the guidelines 
recommending thiazides as first-line treatment of essential hypertension have 
been introduced. Thiazide diuretics act by inhibiting reabsorption of Na
+ and 
Cl¯ from the distal convoluted tubule by blocking the thiazide-sensitive Na
+/Cl
- 
cotransporter. Thus, they inhibit electrolyte transport in the diluting segment and 
may impair urinary dilution in some vulnerable groups. Risk factors predisposing 
to TIH are old age, women, reduced body masses, and concurrent use of other 
medications that impair water excretion. While taking thiazides, the elderly 
may have a greater defect in water excretion after a water load compared with 
young subjects. Hyponatremia is usually induced within 2 weeks of starting 
the thiazide diuretic, but it can occur any time during thiazide therapy when 
subsequent contributory factors are complicated, such as reduction of renal 
function with aging, ingestion of other drugs that affect free water clearance, 
or changes in water or sodium intake. While some patients are volume depleted 
on presentation, most appear euvolemic. Notably serum levels of uric acid, 
creatinine and urea nitrogen are usually normal or low, suggestive of syndrome 
of inappropriate secretion of antidiuretic hormone. Despite numerous studies, 
the pathophysiological mechanisms underlying TIH are unclear. Although 
the traditional view is that diuretic-induced sodium or volume loss results in 
vasopressin-induced water retention, the following 3 main factors are implicated 
in TIH: stimulation of vasopressin secretion, reduced free-water clearance, and 
increased water intake. These factors will be discussed in this review. 
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Introduction
Thiazide diuretics include all diuretics believed to have 
a primary action to inhibit NaCl reabsorption in the 
distal convoluted tubule (Table 1) and have been used 
in the management of hypertension for over 50 years
1, 
2). These agents decrease blood pressure (BP) when 
administered as monotherapy, enhance the efficacy of 
other antihypertensive agents, and reduce hypertension-
related morbidity and mortality. However, the use of 
thiazide diuretics is often limited by concerns about some 
metabolic change, e.g., hyponatremia, hypokalemia and 
insulin resistance
3). 
Hyponatremia is an occasional but potentially fatal 
complication of diuretic therapy. The first detailed 
description of diuretic-induced hyponatremia was 
published over 35 years ago
4). Since that time, numerous 
additional cases have been reported. Thiazides are a 
common cause of severe hyponatremia in hospitalized 
patients
5) and are associated with high morbidity and 
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mortality
6, 7). 
Virtually all cases of severe diuretic-induced hypo-
natremia have been due to a thiazide-type diuretic
6-12). 
In contrast, loop diuretics are implicated much less 
commonly
7). This observation is probably derived from 
the different nephronal sites of action of these two classes 
of diuretics. Thiazide diuretics inhibit NaCl reabsorption 
in the distal convoluted tubule, the main diluting site 
of the nephron. Thus, thiazide diuretics interfere with 
maximum dilution of urine because sodium (Na
+) 
excretion is increased along with diminished free-water 
excretion
13, 
14). On the other hand, loop diuretics inhibit 
NaCl reabsorption in the thick ascending limb of the loop 
of Henle. The reabsorption of NaCl without water in the 
medullary thick ascending limb is normally the primary 
step in the generation of the hypertonicity in the medullary 
interstitium, and loop diuretics mainly impair urinary 
concentration and limit water retention and development 
of hyponatremia
15). 
Although thiazide diuretics are frequently recommended 
as the first-line anti-hypertensive according to the practice 
guidelines and results of the major clinical trials such as 
the Antihypertensive and Lipid-Lowering Treatment to 
Prevent Heart Attack Trial (ALLHAT)
16-18), the mechanism 
and optimal treatment of thiaizde-induced hyponatremia 
(TIH) remain unclear. In this review, we will explore the 
pathogenesis, discuss the clinical features, and suggest an 
approach to the treatment of TIH.
Epidemiology of TIH
Electrolyte disturbance is common after administration 
of thiazide diuretics, and hyponatremia is a typical com-
plication with an estimated incidence of 11% in one series 
of 114 geriatric patients
19). In the Systolic Hypertension 
in the Elderly Program (SHEP), which focused on older 
patients, hyponatremia was observed in 4.1% of patients 
treated with chlorthalidone versus 1.3% in the control 
group
20). Thirty percent of patients were receiving 12.5 
mg/day of chlorthalidone, and 60% were receiving 25 
mg/day
20). In another study on elderly patients, diuretic-
induced hyponatremia was seen in 17% and hypokalemia 
in 6.6%
21). Fifty three percent of patients were receiving 
a thiazide diuretic and 24% a loop diuretic
21). In patients 
with TIH, an average daily hydrochlorothiazide dose of 
35 mg has been reported, with 44% of patients having 
received ≥50 mg
22). On the other hand, in 10% of the 
cases with TIH the dose was only 12.5 mg
23). Considering 
the high prevalence of hypertension in the elderly and the 
routine use of thiazide diuretics to treat it, TIH is clearly a 
prevalent problem. 
The question arises as to whether a certain subgroup of 
patients is susceptible to this adverse effect of thiazides. 
The risk factors of TIH are old age, women, reduced body 
mass
7, 9, 13, 14, 22, 24), and concurrent use of other medications 
that impair water excretion
13, 25). As shown in Table 2 
which was obtained by the recent nephrology consultation 
in our hospital, old women are clearly predisposed to TIH.
According to the experiment done by Clark et al.
13), 
healthy elderly subjects do not excrete free water as 
efficiently as younger ones do. In particular, elderly subjects 
with a previous history of TIH have impaired urinary 
dilution capacity, and hence, increased susceptibility to 
TIH. Among the explanations, blunted prostaglandin 
synthesis is an attractive possibility
25), and could result from 
aging or propensity among the elderly for polypharmacy, 
including non-steroidal anti-inflammatory agents. 
The reason why individuals with reduced body mass 
are more prone to complications from diuretics remains 
Table 1. Thiazide Diuretics
Thiazide-type (presence of a benzothiadiazine structure)
Chlorothiazide
Hydrochlorothiazide
Methylchlothiazide
Polythiazide
Bendroflumethiazide
Thiaizde-like (mechanism of action similar to that of thiazide-type 
diuretics)
Metolazone
Chlorthalidone
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puzzling. Plasma Na
+ level is determined by the ratio 
between the amount of exchangeable Na
+ and potassium 
(K
+) and the total body water
26). Thus, it is conceivable that 
Na
+ concentration might change to a greater degree in a 
subject with smaller body size, and hence less total body 
water. Besides, small body mass or muscle wasting might 
also signify underlying illness
27).
Numerous case reports have indicated that hypertensive 
women are particularly at risk to develop hyponatremia
7, 
9, 13, 14, 22, 24). The reason that women are more susceptible 
to the effects of thiazide diuretics than men is unknown. 
Women probably drink more than men to compensate 
for the diuretic and therefore develop more dilutional 
hyponatremia
28), and hypertensive women may be more 
often treated with diuretics than hypertensive men
29). 
Moreover, women may be more symptomatic than men 
at comparable serum Na
+ levels and therefore may be 
diagnosed more often than men
30). 
Clinical characteristics of TIH
The clinical manifestations of TIH are similar to those 
due to other causes of hyponatremia. TIH can develop 
acutely or gradually. It can range from mild to severe and 
from asymptomatic to symptomatic. One of the most 
remarkable features of TIH is the rapidity with which it can 
occur. In susceptible individuals, the serum Na
+ may fall 
within hours of administration
8), and severe hyponatremia 
can develop within less than 2 days
7, 14). In most reported 
cases (50% to 90%) the duration of thiazide use was less 
than 2 weeks
7, 8, 14, 22). However it can occur any time 
during thiazide therapy when sub-sequent contributory 
factors are complicated such as old age, increased water 
intake, low salt intake
7, 9, 13, 14, 22, 24), and concurrent use of 
other medications that impair water excretion
13, 25).
Mild hyponatremia, with serum Na
+ concentration in 
the range of 125 to 132 mEq/L, is usually asymptomatic, 
although vague symptoms such as fatigue or nausea are 
possible
3). More severe hyponatremia, as reported in 
patients who required hospitalization, can be asymptomatic 
or associated with symptoms including weakness, 
vomiting, nausea, confusion, dizziness, abdominal pain, 
and manifestations as serious as lethargy, seizures, and 
coma
11, 22).
The volume status of TIH may be variable. While some 
patients are volume depleted on presentation, most appear 
to be euvolemic
10, 14, 31, 32). Reduced free-water clearance can 
explain why many patients with TIH behave as if they are 
volume expanded; the body weight may initially increase
8). 
In patients with TIH, blood urea nitrogen (BUN) and 
plasma creatinine concentration are generally low-normal
10, 
33), and hypouricemia due to enhanced urinary uric 
acid excretion may be present
32, 33). All of these findings 
are similar to those in the syndrome of inappropriate 
antidiuretic hormone secretion (SIADH), which is also 
associated with initial volume expansion. The laboratory 
data from our TIH patients are also compatible with 
those of SIADH (Table 2), similarly to reports from other 
studies
8-11, 13). According to Sonnenblick et al.
32), elevated 
fractional uric acid clearance and low serum uric acid level 
were useful to determine that TIH was more favored than 
furosemide-induced hyponatremia. 
Pathogenesis of TIH
Despite numerous studies, the pathophysiological 
mechanisms underlying TIH are unclear. Although the 
traditional view is that diuretic-induced Na
+ or volume 
Table 2. Data from Patients (n=14) with Hydrochlorothiazide-Induced 
Hyponatremia 
Gender (M/F) 
Age (years)
Serum Na
+ (mEq/L) 
Serum osmolality (mOsm/kg)
Serum K
+ (mEq/L)
Serum Clˉ (mEq/L) 
Serum total CO2 (mEq/L) 
Urine osmolality (mOsm/kg)
Urine Na
+ (mEq/L)
BUN (mg/dL) 
Serum creatinine (mg/dL)
Serum uric acid (mg/dL)
 0 / 14
78±6 (62-87)
118±6 (106-128)
241±11 (221-256)
3.5±0.6 (2.2-4.1)
82±8 (70-96) 
23.4±2.8 (20.1-28.4)
391±119 (215-584)
91±51 (15-194)
12±4 (7-18) 
0.7±0.2 (0.4-1.1)
3.1±1.0 (1.5-4.9)
Continuous parameters are described as mean±SD (range). BUN, blood 
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loss results in vasopressin-induced water retention, the 
following 3 main factors are implicated in TIH: increased 
water intake, reduced free-water clearance and renal Na
+ 
and/or K
+ loss (Table 3).
There is evidence that water intake is maintained or 
increased in many patients with TIH
6, 8, 27). Friedman 
et al.
8) showed that within 6 hours of ingesting a single 
hydrochlorothiazide-amiloride tablet, previously affected 
patients had a small rise in urine osmolality and a fall in 
serum Na
+ of 5.5 mEq/L in association with a small gain 
in weight; controls had only a slight fall in serum Na
+, 
and their mean weight fell. Although water intake was not 
measured, the authors suggested that thiazides might cause 
polydipsia, which, when combined with the renal effects, 
results in expansion of total body water and development 
of hyponatremia. Stimulation of water intake would not 
only help defend the extracellular volume, but would also 
explain why thiazides are one of the most common causes 
of severe hyponatremia. 
Increased water intake would not lead to hyponatremia 
unless impairment in water excretion exists. While 
thiazide diuretics do not inhibit concentrating ability, 
they do impair diluting ability in several ways
15, 26, 34). As 
mentioned above, they inhibit electrolyte transport at the 
cortical diluting sites, thereby raising the minimum urinary 
osmolality
34-36). Diuretics may also reduce glomerular 
filtration rate and enhance reabsorption of Na
+ and water 
in the proximal nephron, diminishing fluid delivery to 
the distal diluting sites
35). Thus, water can be retained 
independent of serum osmolality. Besides, thiazide-induced 
volume depletion probably contributes to the genesis of 
TIH in some cases. Hypovolemia may stimulate the release 
of vasopressin because non-osmotic vasopressin secretion is 
very common in normovolemic and hypovolemic types of 
hyponatremia
31).
Thiazides may directly affect water permeability 
in the collecting duct epithelia
37). A previous in vitro 
microperfusion study showed that hydrochlorothiazide 
enhanced water absorption in the inner medullary 
collecting duct from normal rats and Brattleboro rats as 
well
38). Consistent with this, Kim et al. reported that the 
paradoxical antidiuresis induced by hydrochlorothiazide 
in nephrogenic diabetes insipidus was associated with 
upregulation of aquaporin-2 in the collecting duct
39). 
There is much evidence that patients with TIH are 
electrolyte-deficient. First, virtually all relevant studies 
have found that during the development of TIH, Na
+ 
balance is negative
4, 6, 10). Fuisz et al. argued that changes 
in external Na
+ and water balance did not completely 
account for the fall in serum Na
+4). Furthermore, 
chlorothiazide induced hyponatremia in their patients 
despite Na
+ supplementation and positive Na
+ balance. 
These observations led the authors to conclude that a 
shift of Na
+ into the intracellular space contributed to the 
pathogenesis of hyponatremia. Second, once diuretics 
are withdrawn, urinary Na
+ excretion falls to very low 
levels
4, 10). Third, many of these patients are hypokalemic
4, 
6, 10). Fichman et al.
10) emphasized the importance of K
+ 
depletion in TIH. The great majority of their 25 patients 
was hypokalemic, and hyponatremia was corrected in 
4 of them by K
+ repletion despite continued diuretic use 
and Na
+ restriction. These investigators argued that K
+ 
depletion predisposes the patients to hyponatremia because 
the serum Na
+ concentration is dependent upon the ratio 
of the sum of exchangeable Na
+ and K
+ to total body 
water. They also speculated that K
+ depletion might cause 
a shift of Na
+ into the intracellular space, thereby further 
compromising the extracellular volume and stimulating 
vasopressin release. Na
+ and/or K
+ depletion alone would 
not be expected to cause marked hyponatremia because 
water excretion normally increases as the serum Na
+ 
concentration falls. However, because thiazides interfere 
with renal water excretion, they impair this normal 
Table 3. Contributory Factors for Thiazide-Induced Hyponatremia
1. Excess free-water intake
Increased water intake
Low salt intake
2. Reduced free-water clearance
Reduced renal capacity to excrete free-water, usually age-related
Stimulation of vasopressin release
Ingestion of other drugs that impair free-water clearance
3. Renal Na
+ and/or K
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osmoregulatory response. Thus, as in most patients with 
hyponatremia, urine osmolality is inappropriately high 
relative to the osmolality of plasma and often exceeds it
4, 6, 
10, 31, 32).
Several drugs increase the likelihood of developing 
TIH. Nonsteroidal anti-inflammatory drugs, through 
prostaglandin inhibition, decrease free-water clearance
13, 
25). Drugs such as chlorpropamide or selective serotonin 
reuptake inhibitors may be associated with SIADH
3). 
Polydipsia caused by psychotropic medications also 
predisposes to TIH
3).
Management of TIH
The acute management of TIH is more determined by 
the presence or absence of neurologic symptoms than by 
the Na
+ level per se. Treatment consists of discontinuing 
thiazides, regular diet (usually supplemented with K
+) 
restricting water, administration of furosemide and 
either isotonic saline or, if the hyponatremia is severe or 
symptomatic, hypertonic saline. 
In patients with hypovolemic TIH, in whom vasopressin 
secretion stimulated by hypovolemia contributes to the 
inability to excrete free water, normal saline infusion is 
appropriate because it will restore volume and suppress 
vasopressin release. In patients with severe manifestations 
such as seizures or coma, initiation of treatment with 
hypertonic saline to assure rapid onset of response is 
recommended
3, 16). We treated our patients with TIH using 
either isotonic or 3% hypertonic saline (Table 4). The data 
suggest that the severity of hyponatremia might influence 
the choice between isotonic and hypertonic saline.   
In patients with euvolemia or hypervolemia-associated 
hyponatremia, who tend to have lower serum levels of 
uric acid, BUN, and creatinine, normal saline will not 
restore free-water clearance or serum Na
+ concentration. 
In such patients, hypertonic saline will predictably raise 
serum Na
+ concentration and is preferable. Administration 
of furosemide in addition to the hypertonic saline can 
increase free-water clearance and thus hasten the increase 
of the serum Na
+ concentration while avoiding volume 
overload
5).
In asymptomatic or minimally symptomatic patients, 
stopping the offending diuretic and restricting water intake 
to <1 L/day is usually all that is needed. Normal saline 
is not needed unless correction of volume depletion is 
indicated. Increasing oral salt intake in combination with 
fluid restriction can increase serum Na
+ concentration
3). 
Prevention of TIH
How can TIH be prevented? There are no guidelines 
regarding measures to prevent TIH. The first step in 
prevention of TIH is awareness that it can happen, 
particularly in the elderly, female, or small individuals. In 
susceptible individuals, the serum Na
+ may fall in hours of 
diuretic ingestion, and severe hyponatremia can develop 
within 2 days
7, 14). Therefore in susceptible patients, serum 
Na
+ should be measured within one day after beginning 
therapy. If the serum Na
+ level falls more than a few mEq/L, 
the diuretic should be stopped. If there is little or no change 
in the serum Na
+, it should be rechecked 1-2 days later to 
be sure the level is stable
14). 
Identifying patients with excessive fluid intake and 
counseling them to reduce their intake would be extremely 
helpful and cost-effective. When prescribing thiazides, low 
doses should be used
3). Only 10% of TIH cases occur at 
low dosage
19, 20, 22). A lower dose would increase the ability 
to excrete free-water, would reduce the hypovolemic 
Table 4. Comparison of Biochemical Data According to Saline 
Preparations Used in Treatment of Thiazide-Induced Hyponatremia
Hypertonic saline 
(n=5)
Isotonic saline 
(n=9)
P*
Serum Na
+ (mEq/L)
Serum K
+ (mEq/L)
Serum total CO2 (mEq/L)
BUN (mg/dL)
Uric acid (mg/dL)
Urine osmolality (mOsm/kg)
Urine Na
+ (mEq/L)
112±4
3.5±0.4
21.9±1.6
12±4
3.4±1.0
478±117
96±63
121±5
3.5±0.7
24.2±3.1
12±4
2.9±1.0
343±94
88±47
0.009
NS
NS
NS
NS
0.053
NS
Data are presented as mean±SD. 
BUN, blood urea nitrogen; NS, not significant.
* Comparison was performed by Mann-Whitney U test.56      KS Hwang et al.  •  Thiazide-Induced Hyponatremia
Copyright © 2010 The Korean Society of Electrolyte Metabolism
stimulus for vasopressin secretion, and can correct 
borderline hyponatremia in many cases
3). Even patients 
who have done well on chronic thiazide therapy may 
develop severe hyponatremia if water intake increases. 
Therefore, all patients using these drugs should be educated 
about the danger of drinking excessive water
3, 14). 
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